To navigate this increasingly complex environment in 2025, pharma manufacturers must fundamentally rethink their models and ...

Becker's asked pharmacy executives from hospitals and health systems across the U. S. to share the areas they're focusing on for 2025.

The Science Based Targets initiative was seen as the benchmark for corporate climate ambition, but is now trying to stay ...

The top gastroenterology biosimilar news from 2024 highlight fluctuations in the adalimumab biosimilar market throughout the ...